Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
May. 09 | Cullinan Therapeutics Insider Sold Shares Worth $1,796,676, According to a Recent SEC Filing | MT |
May. 01 | Stifel Initiates Cullinan Oncology With Buy Rating, $40 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-.--% | 4M | |
+13.14% | 5.08B | |
-4.94% | 3.66B | |
+7.66% | 1.63B | |
+43.04% | 1.35B | |
+82.85% | 881M | |
+22.38% | 854M | |
+24.19% | 609M | |
-28.34% | 535M | |
-.--% | 156M |
- Stock Market
- Equities
- CGEM Stock
- News Consolidated Gems, Inc.
- BTIG Adjusts Price Target on Cullinan Oncology to $30 From $20, Maintains Buy Rating